Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer [Phase 3]
A Phase 3 clinical trial update indicates docetaxel for injection (albumin-bound) is being studied in gastric cancer and is currently recrui…
-
FDA approval · 2024-11-13FDA Approved: OGIVRI — Supplemental Application (Biocon Biologics Inc.)
The FDA approved a supplemental application for OGIVRI (trastuzumab-dkst) from Biocon Biologics Inc.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 3]
Phase 3 trial comparing chemotherapy alone versus chemotherapy plus surgical resection for limited-metastatic gastric cancer or gastroesopha…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Tislelizumab Combined with SOX and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Metastasis: a Prospective Cohort Study
A prospective cohort study evaluating tislelizumab in combination with SOX chemotherapy and HIPEC for gastric cancer with peritoneal metasta…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC [Phase 2]
A Phase 2 clinical trial is evaluating mecapegfilgrastim combined with adebrelimab and chemotherapy as neoadjuvant therapy for resectable ga…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) [Phase 3]
This Phase 3 trial (PREVENT) is comparing HIPEC plus FLOT to FLOT alone in gastric cancer and gastroesophageal junction adenocarcinoma. The …
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Endoscopic Submucosal Dissection Registry
An ongoing clinical trial registry update for an Endoscopic Submucosal Dissection registry sponsored by Carol Davila University of Medicine …
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery
The update discusses how splenic artery characteristics may influence outcomes in gastric cancer surgery, and notes the trial is currently a…
-
CLINICAL_TRIALS withdrawal · 2024-11-06Clinical Trial Update: Perioperative Chemotherapy in Gastric Cancer [Phase 2]
A Phase 2 trial evaluating perioperative chemotherapy for gastric cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer
This completed clinical trial compares upfront surgery with neoadjuvant therapy followed by surgery for node-negative gastric cancer and rep…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer [Phase 2]
A Phase 2 trial comparing nab-paclitaxel plus a PD-1 inhibitor versus nab-paclitaxel alone as second-line therapy in advanced gastric and ga…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer [Phase 2]
Phase 2 trial evaluating octreotide to improve nutritional recovery after surgery in patients with esophageal or gastric cancer has complete…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer
This completed real-world data study compares paclitaxel plus ramucirumab against other regimens in second-line treatment of advanced gastri…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors [Phase 1]
Phase 1 trial update for IMM2902, a HER2/SIRPα bispecific antibody-receptor fusion protein, in patients with HER2-expressing advanced cancer…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer [Phase 2]
A Phase 2 clinical trial is evaluating SHR-A1811 in combination with Apatinib for advanced gastric cancer, gastroesophageal junction adenoca…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 trial of CCT301-59 CAR T therapy in adults with recurrent or refractory solid tumors has been terminated. The study included soft ti…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors [Phase 1]
A Phase I trial evaluating CCT303-406 in relapsed or refractory HER2-positive solid tumors is active but not recruiting, including gastric c…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: IMmune Proteomics to Predict neoAdjuvant Chemotherapy and immunoTherapy Response in Gastric Cancer
Clinical trial investigating immune proteomics to predict response to neoadjuvant chemotherapy and immunotherapy in gastric cancer; currentl…
-
CLINICAL_TRIALS withdrawal · 2024-10-26Clinical Trial Update: An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study [NA]
A clinical trial evaluating an exercise and nutrition monitoring intervention for strengthening patients with gastric or pancreatic cancer u…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: HIPEC for Peritoneal Carcinomatosis [Phase 2]
This update reports results from a Phase 2 clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcin…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma [Phase 2]
Phase 2 trial evaluating BGB-A317 in combination with chemotherapy as first-line treatment for adults with inoperable, locally advanced, or …
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer [Phase 1]
First-in-human Phase 1 trial of TORL-2-307-MAB in participants with advanced cancer, including gastric cancer, pancreatic cancer, and gastro…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer [Phase 1, Phase 2]
Clinical trial update on MRG002 in patients with HER2-positive advanced solid tumors and locally advanced or metastatic gastric/GEJ cancer, …
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
This clinical trial update describes a study sponsored by Union Hospital and Tongji Medical College testing an AI-based multi-modal informat…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy [NA]
A completed clinical trial evaluating the Halcyon 4.0 imaging system for patients receiving radiation therapy across several cancers.